cardiovascular system
• increase in pericytes in the left ventricle
|
• hearts exhibit the presence of pre-amyloid oligomers at 1 year of age
|
• increase in cardiomyocyte size
• however, no alterations in sarcomere structure are seen
|
• hearts exhibit an increase in numbers of activated cardiac fibroblasts in the left ventricle and an increase in pericytes
• however, no increase in fibrosis is seen
|
• hearts exhibit significant dilatation at 8 months of age
• however, no difference in left ventricle mass or heart weight is seen at 12 months of age
|
• echocardiography and Doppler analysis indicate progressive heart failure, however no evidence of congestive heart failure, such as fluid accumulation in the lungs, is seen
|
• systolic dysfunction is seen by 8 months of age and indicated by decreased fractional shortening and ejection fraction
|
• Doppler analysis on the mitral valve shows an E/a waveform ratio of 1.0 compared to 2.0 in wild-type mice indicating reduced diastolic function
|
• transthoracic echocardiography indicates decreased anterior wall thickness in systole at 8 months, increased left ventricular end-systolic dimension at 8 and 12 months, decreased posterior wall thickness in diastole at 12 months, decreased left ventricular % ejection fraction at 8 and 12 months, and increased left ventricle volume in diastole at 12 months and in systole at 8 and 12 months
|
• increase in infiltrating immune cells in the heart
|
cellular
• mitochondria show a mild decrease in area in the heart
|
• increase in mitochondria in the heart
|
immune system
• increase in infiltrating immune cells in the heart
|
muscle
• increase in cardiomyocyte size
• however, no alterations in sarcomere structure are seen
|
• systolic dysfunction is seen by 8 months of age and indicated by decreased fractional shortening and ejection fraction
|
• Doppler analysis on the mitral valve shows an E/a waveform ratio of 1.0 compared to 2.0 in wild-type mice indicating reduced diastolic function
|
growth/size/body
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
myofibrillar myopathy 6 | DOID:0080097 |
OMIM:612954 |
J:234278 |